Ibnsina Pharma

EGX-ISPH
Egyptian Stock Exchange
Drugs, Drug Proprietaries, and Druggists' Sundries
Global Rank
#20736
Country Rank
#52
Market Cap
183.05 M
Price
0.182
Change (%)
1.10%
Volume
3.99 M

Ibnsina Pharma's latest marketcap:

183.05 M

As of 07/05/2025, Ibnsina Pharma's market capitalization has reached $183.05 M. According to our data, Ibnsina Pharma is the 20736th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 183.05 M
Revenue (ttm) 1.23 B
Net Income (ttm) 11.18 M
Shares Out 1.01 B
EPS (ttm) 0.01
Forward PE 8.16
Ex-Dividend Date n/a
Earnings Date 08/13/2025
Market Cap Chart
Data Updated: 07/05/2025

Ibnsina Pharma's yearly market capitalization.

Ibnsina Pharma has seen its market value drop from 5.44 B EGP to 183.05 M EGP since 2017, representing a total decrease of 96.64% and an annual compound decline rate (CAGR) of 36.31%.
Date Market Cap(EGP) Change (%) Global Rank
07/05/2025 183.05 M 31.29% 20736
12/31/2024 7.06 B 100.64% 21369
12/31/2023 3.52 B 45.37% 22315
12/29/2022 2.42 B -38.08% 22514
12/30/2021 3.91 B -20.04% 17616
12/31/2020 4.89 B -39.01% 14379
12/31/2019 8.01 B 17.46% 10093
12/31/2018 6.82 B 25.31% 10543
12/28/2017 5.44 B 12848

Company Profile

About Ibnsina Pharma

Ibnsina Pharma is a leading pharmaceutical distributor based in Egypt, specializing in the supply of pharmaceutical and cosmetic products to a diverse range of clients.

Products & Services

  • Distribution of pharmaceutical and cosmetic products to retail chains, independent pharmacies, wholesalers, hospitals, and healthcare institutions.
  • Warehousing and logistics support for suppliers.
  • Marketing solutions tailored to client needs.
  • Importation, packaging, and market research services.
  • Value-added services to enhance customer experience.

Company Background

Founded in 2001, Ibnsina Pharma is headquartered in El Obour City, Egypt, and has established itself as a trusted partner in the pharmaceutical distribution sector.

Frequently Asked Questions

  • What is Ibnsina Pharma's (EGX-ISPH) current market cap?
    As of 07/05/2025, Ibnsina Pharma (including the parent company, if applicable) has an estimated market capitalization of $183.05 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • Ibnsina Pharma global market capitalization ranking is approximately 20736 as of 07/05/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.